BGN Technologies, the technology transfer company for Ben-Gurion University of the Negev (BGU), has signed a licensing agreement for its V-Smart drug delivery technology with Lauren Sciences LLC, a privately held biotechnology company in New York. Lauren Sciences will develop the technology as a platform for treating a variety of diseases that affect the central nervous system, including Parkinson’s, Alzheimer’s and Amyotrophic Lateral Sclerosis (ALS). The V-Smart technology pinpoints where the drug will be released in the brain, to increase efficacy and reduce adverse effects.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Israel Foodtech Firms Meet UK Retailers, Investors In London
April 17, 2024
Facebook comments